Operational clarity
Unified picture of capacity, throughput, and bottlenecks.
Healthcare. Operations, research, safety.
European healthcare systems navigate enormous complexity: clinical, operational, regulatory. Lives depend on the quality of decisions and the speed of coordination — under GDPR and EHDS rules that brook no shortcuts.
How Raven supports Healthcare
Raven helps European providers, payers, and researchers turn fragmented data into operational clarity — coordinating care pathways, monitoring safety signal, accelerating research, and freeing clinicians from administrative drag. Designed against GDPR and the European Health Data Space from day one.
Use cases
Where Raven moves the needle.
Safety surveillance
Detect adverse-event patterns across populations and sites.
Research acceleration
Reasoning-grade tools to navigate evidence and prior literature.
Care coordination
Workflows that route the right context to the right caregiver, on time.
Regulatory context · EU
Designed against the rules Healthcare actually operates under.
Raven is built in Europe, for institutions operating under EU rules. The platform is aligned with the regulatory environment from day one — not retrofitted to it.
GDPR (health data)EU
Article 9 special-category data handled with explicit consent flows, scoped processing, and full audit.
EHDSEU
Designed for the European Health Data Space — primary and secondary use of health data with cross-border interoperability.
MDR / IVDREU
Audit chain compatible with medical-device regulation requirements for software components.
EU AI Act (high-risk)EU
Article 14 human-oversight obligations met by default in Huginn for clinical-decision-support uses.
Operating scenario
Pharmacovigilance signal review. In one afternoon.
How a European teaching hospital uses Huginn to review an emerging adverse-event pattern that used to take a working week.
- Step T+0Detect
Muninn correlates adverse events across sites.
Muninn surfaces an emerging pattern across three hospital sites and two patient cohorts — visible only because the signal crosses both EHR records and external pharmacovigilance feeds.
- Step T+1hInvestigate
Huginn assembles the evidence case.
A pharmacovigilance officer opens a Huginn case, attaches the affected cohorts, the relevant prior literature, and the supplier and lot information. Adversarial review tests confounders.
- Step T+5hDecide
Committee approves and reports.
The committee reviews the signed case, approves a precautionary protocol change for the affected cohort, and Huginn exports the regulator submission with the full evidence chain attached.
Recommended stack